Akkermansia muciniphila PROBIO ameliorates overweight via gut microbiota modulation：a randomized controlled trial

 

 

 

Inactivated Akkermansia muciniphila AKK PROBIO Preserves Intestinal Homeostasis and Ameliorates DSS-Induced Colitis in Mice

 

 

 Pasteurized Akkermansia muciniphila AKK PROBIO Attenuates Obesity Through Gut Microbiota-SCFA-GLP-1 Axis and Potential Involvement of AMPK/PPAR-α Pathway

 

 

 

Heat-inactivated Akkermansia muciniphila AKK-PROBIO ameliorates cyclophosphamide-induced immunosuppression via the NF-κB/MAPK pathway and gut microbiota modulation

 

 

 

Characterization and Preliminary Safety Evaluation of Akkermansia muciniphila PROBIO

 

 

Akkermansia muciniphila PROBIO therapy promotes arginine biosynthesis and reverses reproductive impairments in polycystic ovary syndrome rats

 

 

 

The alleviating effect of Akkermansia muciniphila PROBIO on AOM/ DSS-induced colorectal cancer in mice and its regulatory effect on gut microbiota

 

 

 

Immune restoration mechanism analysis of Akkermansia PROBIO in mice treated with cyclophosphamide through Re-balancing microbiota composition

 

 

 

Supplementation of Akkermansia muciniphila improves diabetic kidney disease by regulating gut microbiome in db/db mice

 

 

Research on preventive effect of Akkermansia muciniphila AKK PROBIO on acute gouty arthritis in mice

 

 

Heat-inactivated Akkermansia muciniphila AKK PROBIO attenuates hyperuricemia via integrated modulation of uric acid metabolism, TLR4/ NF-κB/NLRP3 pathway, and gut microbiota